WRCDF yields 666666.67% · JNJ yields 2.13%● Live data
📍 WRCDF pulled ahead of the other in Year 1
Combined, WRCDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WRCDF + JNJ for your $10,000?
Wirecard AG, a technology company, provides outsourcing and white label solutions for electronic payments worldwide. The company operates in three segments: Payment Processing & Risk Management, Acquiring & Issuing, and Call Center & Communication Services. The Payment Processing & Risk Management segment offers products and service for the acceptance or transactions, and the processing of electronic payments and associated processes. The Acquiring & Issuing segment provides settlement services for credit card sales for online and terminal payments, as well as current accounts with prepaid cards and Girocard/Maestro debit cards; processes payment transactions in various currencies; and issues prepaid and debit cards to private and business customers. The Call Center & Communication Services segment offers value added services, aftersales services to customers, and mailing services. The company also provides payment processing solutions that include Wirecard Payment Page, a payment page; credit card processing; direct debit; online banking payment; alternative payment; international payment processing; tokenization; point of sale terminals; and Wirecard Checkout Portal, a payment portal. In addition, it offers mobile payment solutions; risk management solutions, such as fraud prevention, credit worthiness checks, and individual solutions; integration and testing solutions, including enterprise integration, transaction testing, payment hub, customer self-select PIN, and secure mailer solutions; and communication services. The company serves the consumer goods, digital goods, and travel and mobility sectors. Wirecard has strategic partnerships with Poynt, CreditPilot PLC, SunExpress, and Emonvia. Wirecard AG was founded in 1999 and is headquartered in Aschheim, Germany.
Full WRCDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.